Sur cette page
CRIS Curis, Inc. - Common Stock
NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 14, 2026
$0,80
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$0,80Bas 52 semaines
$34,40Haut 52 semaines
Capitalisation Boursière (MRQ)
$2M
P/E (TTM)
-0.2
BPA (TTM)
$-3.92
Revenu (TTM)
$4M
vos badges
Fourchette 52 semaines
$1–$34
Note des analystes
BUY
Objectif de cours
$43
P/E
-0.2
ROE
455.3%
Marge nette
-490.3%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
CRIS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.80
Capitalisation Boursière (MRQ)
$2M
P/E (TTM)
-0.2
BPA (TTM)
$-3.92
Revenu (TTM)
$4M
ROE (TTM)
455.3%
Dette/Capitaux propres
0.0
Fourchette 52 semaines
$1–$34
CRIS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Splits d'actions
| Date ex-dividende | Division | Type |
|---|---|---|
| 6 juillet 2026 | 1-for-20 | Inverse |
| 29 septembre 2023 | 1-for-20 | Inverse |
| 30 mai 2018 | 1-for-5 | Inverse |
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$9M2016-12-31 → 2025-12-31
BPA$-0.582019-12-31 → 2025-12-31
Flux de trésorerie libre·2016-12-31 → 2023-12-31
Marge nette-490.3%2016-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | CRIS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.2moyenne 5 ans ≈37.2 | ≈37.2 | · | · | |
| P/S (TTM) | 0.4moyenne 5 ans ≈207.6 | ≈207.6 | · | · | |
| P/B (MRQ) | 0.3moyenne 5 ans ≈24.5 | ≈24.5 | · | · | |
| EV / EBITDA | 0.8moyenne 5 ans ≈-68.8 | ≈-68.8 | · | · | |
| Price / Cash Flow (Cours / Flux de trésorerie) | -0.0moyenne 5 ans ≈-58.8 | ≈-58.8 | · | · | |
| EV / Revenue (VE / Chiffre d'affaires) | -0.5moyenne 5 ans ≈270.2 | ≈270.2 | · | · | |
| Price / Tangible Book (Cours / Actif net tangible) | 0.3moyenne 5 ans ≈47.4 | ≈47.4 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | CRIS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -203.2%moyenne 5 ans ≈-336.5% | ≈-336.5% | · | · | |
| EBITDA Margin (Marge EBITDA) | -60.5%moyenne 5 ans ≈-336.5% | ≈-336.5% | · | · | |
| Marge nette (TTM) | -490.3%moyenne 5 ans ≈-344.4% | ≈-344.4% | · | · | |
| ROA (TTM) | -87.8%moyenne 5 ans ≈-43.4% | ≈-43.4% | · | · | |
| ROE (TTM) | 455.3%moyenne 5 ans ≈131.9% | ≈131.9% | · | · |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | CRIS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (Dette / Capitaux propres) | 0.0moyenne 5 ans ≈-0.4 | ≈-0.4 | · | · | |
| Ratio de liquidité (MRQ) | 0.5moyenne 5 ans ≈3.9 | ≈3.9 | · | · | |
| Quick Ratio (Ratio de liquidité réduite) | 0.4moyenne 5 ans ≈3.7 | ≈3.7 | · | · |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | CRIS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | -13.4%moyenne 5 ans ≈-2.5% | ≈-2.5% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | -2.4%moyenne 5 ans ≈-1.4% | ≈-1.4% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | -2.7% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | CRIS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.3moyenne 5 ans ≈0.2 | ≈0.2 | · | · | |
| Receivables Turnover (Rotation des créances) | 5.6moyenne 5 ans ≈4.0 | ≈4.0 | · | · | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$472.1K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-16.7%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 14, 2026 | $-4.02 | $-8.00 | 49.7% |
| 31 mars 2026 | $-25.00 | $-8.16 | -206.4% | |
| 31 décembre 2025 | $-10.00 | $-9.18 | -8.9% | |
| 30 septembre 2025 | $-9.80 | $-11.79 | 16.9% | |
| 30 juin 2025 | $-13.60 | $-18.16 | 25.1% | |
| 31 mars 2025 | $-1.25 | $-1.21 | -3.2% | |
| 31 décembre 2024 | $-1.25 | $-1.39 | 9.9% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $11M | $10M | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $10M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $18M | · | $14M | |
| SG&A Expense | $14M | $17M | $19M | $20M | $17M | $12M | $12M | $15M | $14M | $16M | $13M | $12M | |
| Operating Expenses | $42M | $55M | $58M | $63M | $53M | $36M | $34M | $40M | $60M | $66M | $64M | $26M | |
| Operating Income | $-6M | $-45M | $-48M | $-53M | $-42M | $-25M | $-24M | $-29M | $-50M | $-58M | $-56M | $-16M | |
| Interest Expense | · | · | · | · | $0 | $0 | $791.0K | $4M | $4M | $3M | $3M | $4M | |
| Interest Income | $316.0K | $2M | $3M | $1M | $211.0K | $63.0K | $614.0K | $684.0K | $513.0K | $406.0K | $277.0K | $165.0K | |
| Other Non-op | $-2M | $1M | $919.0K | $-4M | $890.0K | $22.0K | $-58.0K | $0 | $-4M | $-2M | $-2M | $-3M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-8M | $-43M | $-47M | $-57M | $-45M | $-30M | $-32M | $-33M | $-53M | $-60M | $-59M | $-19M | |
| EPS (Basic) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · | |
| EPS (Diluted) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · | |
| Shares (Basic) | 13,164,032 | 6,306,284 | 5,293,294 | 4,669,626 | 91,569,154 | 48,670,381 | 33,180,516 | · | · | · | · | · | |
| Shares (Diluted) | 13,164,032 | 6,306,284 | 5,293,294 | 4,669,626 | 91,569,154 | 48,670,381 | 33,180,516 | · | · | · | · | · | |
| EBITDA | $-6M | $-45M | $-48M | · | $-42M | $-25M | $-24M | $-29M | $-50M | $-58M | $-56M | $-16M |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $20M | $27M | $20M | $40M | $130M | $15M | $24M | $38M | $26M | $33M | $8M | |
| Short-term Investments | · | $0 | $30M | $66M | $76M | $39M | $5M | $634.0K | $22M | $18M | $49M | $42M | |
| Receivables | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Prepaid Expense | $2M | $3M | $2M | $4M | $3M | $1M | $1M | $827.0K | $989.0K | $1M | $1M | $489.8K | |
| Current Assets | $7M | $26M | $61M | $92M | $122M | $173M | $25M | $28M | $64M | $48M | $86M | $52M | |
| PP&E (Net) | $62.0K | $231.0K | $434.0K | $689.0K | $505.0K | $663.0K | $154.0K | $267.0K | $400.0K | $400.0K | $300.0K | $407.7K | |
| PP&E (Gross) | $913.0K | $1M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $851.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $2M | $2M | $3M | $2M | $0 | $3.0K | $3.0K | $2.0K | $3.0K | $3.0K | $51.0K | $67.5K | |
| Total Assets | $20M | $41M | $77M | $109M | $162M | $204M | $35M | $37M | $74M | $58M | $95M | $63M | |
| Accounts Payable | $6M | $3M | $3M | $3M | $6M | $4M | $4M | $3M | $5M | $6M | $4M | $2M | |
| Accrued Liabilities | $7M | $7M | $9M | $6M | $6M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Current Liabilities | $14M | $19M | $22M | $10M | $13M | $10M | $7M | $13M | $14M | $14M | $11M | $10M | |
| Capital Leases | $428.0K | $2M | $1M | $3M | $4M | $5M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $334.0K | $0 | $11.0K | $34.0K | $18.0K | $139.0K | $174.0K | |
| Total Liabilities | $15M | $47M | $58M | $62M | $72M | $74M | $69M | $42M | $50M | $28M | $30M | $33M | |
| Long-term Debt | · | · | · | · | · | $891.0K | $0 | $35M | $42M | $20M | $24M | $28M | |
| Total Debt | $0 | $8M | · | · | $0 | $557.0K | $0 | $35M | $42M | $20M | $24M | $28M | |
| Common Stock | $6.0K | $85.0K | $59.0K | $48.0K | $916.0K | $915.0K | $332.0K | $332.0K | $331.0K | $1M | $1M | $872.5K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $810M | |
| Retained Earnings | $-1.25B | $-1.24B | $-1.20B | $-1.15B | $-1.09B | $-1.05B | $-1.02B | $-985M | $-952M | $-899M | $-839M | $-780M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $2M | $2M | $2M | $2M | |
| AOCI | · | $0 | $229.0K | $-186.0K | $-109.0K | $-3.0K | $0 | $0 | $-2.0K | $-4.0K | $28.0K | $-11.0K | |
| Stockholders' Equity | $5M | $-6M | $20M | $47M | $91M | $131M | $-34M | $-4M | $24M | $29M | $65M | $30M | |
| Liabilities + Equity | $20M | $41M | $77M | $109M | $162M | $204M | $35M | $37M | $74M | $58M | $95M | $63M | |
| Shares Outstanding | 646,537 | 8,487,818 | 5,894,085 | 4,830,464 | 91,645,369 | 91,502,461 | 33,241,793 | 33,159,253 | 32,831,380 | 141,124,025 | 128,990,378 | 86,030,811 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $169.0K | $203.0K | $255.0K | $233.0K | $158.0K | $144.0K | $125.0K | $177.0K | $235.0K | $193.0K | $200.0K | $200.0K | |
| Stock-based Comp | $4M | $6M | $6M | $7M | $5M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | |
| Operating Cash Flow | $-27M | $-40M | $-38M | $-54M | $-38M | $-26M | $-26M | $-30M | $-48M | $-36M | $-30M | $-17M | |
| CapEx | · | · | $0 | $416.0K | $0 | $677.0K | $41.0K | $85.0K | $188.0K | $329.0K | $48.0K | $92.0K | |
| Investing Cash Flow | $2M | $29M | $38M | $33M | $-48M | $-49M | $-4M | $21M | $-4M | $30M | $-6M | $16M | |
| Stock Issued | $15M | $12M | $14M | $6M | $0 | $159M | $0 | $0 | $42M | $0 | $65M | $0 | |
| Net Stock Activity | $15M | $12M | $14M | · | $0 | $159M | · | $0 | $42M | $0 | $65M | $282.8K | |
| Financing Cash Flow | $10M | $3M | $8M | $867.0K | $-4M | $189M | $23M | $-6M | $64M | $-1M | $62M | $-1M | |
| Net Change in Cash | $-15M | $-7M | $7M | $-20M | $-90M | $114M | $-7M | $-15M | $12M | $-7M | $25M | $-2M | |
| Free Cash Flow | · | · | $-38M | · | $-38M | $-26M | $-26M | $-30M | $-49M | $-36M | $-30M | $-17M |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -60.5% | -408.3% | -482.2% | · | -395.0% | -229.8% | -243.5% | -281.3% | -502.7% | -771.1% | -716.9% | -161.1% | |
| Net Margin | -80.3% | -397.8% | -473.0% | · | -426.7% | -276.0% | -320.9% | -312.6% | -538.7% | -802.6% | -748.6% | -190.3% | |
| EBITDA Margin | -60.5% | -408.3% | -482.2% | · | -395.0% | -229.8% | -243.5% | -281.3% | -502.7% | -771.1% | -716.9% | -161.1% | |
| ROA | -24.8% | -73.2% | -50.9% | · | -24.8% | -25.0% | -88.6% | -58.7% | -81.1% | -79.1% | -74.9% | -26.2% | |
| ROE | 177.9% | 589.0% | -192.5% | · | -46.9% | -58.6% | 107.1% | 1755.5% | -199.5% | -128.8% | -125.1% | -50.0% |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 1.4 | 4.5 | · | 9.1 | 17.1 | 3.8 | 2.1 | 4.6 | 3.6 | 7.9 | 5.2 | |
| Quick Ratio | 0.4 | 1.2 | 4.4 | · | 8.9 | 17.0 | 3.6 | 2.0 | 4.5 | 3.5 | 7.8 | 5.1 | |
| Debt / Equity | 0.0 | -1.3 | · | · | 0.0 | 0.0 | 0.0 | -7.9 | 1.7 | 0.7 | 0.4 | 1.0 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.0 | -6.4 | 1.5 | 0.5 | 0.3 | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | -30.8 | -7.5 | -12.5 | -20.9 | -17.0 | -4.2 |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | 5.6 | 3.6 | 3.5 | · | 3.4 | 3.4 | 3.3 | 3.5 | 3.6 | 3.3 | 3.9 | 5.7 |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.42 | $-0.71 | $3.34 | · | $0.99 | $1.43 | $-1.02 | $-0.14 | $0.15 | $0.21 | $0.50 | $0.35 | |
| Revenue / Share | $0.72 | $1.73 | $1.89 | · | $0.12 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.07 | $-6.27 | $-7.26 | · | $-0.41 | · | · | · | · | · | · | · | |
| Cash / Share | $0.39 | $2.36 | $4.53 | · | $0.44 | $1.42 | $0.46 | $0.71 | $0.23 | $0.18 | $0.26 | $0.09 | |
| EPS (TTM) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.4% | 8.8% | -1.4% | -4.6% | -1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | 0.80% | -2.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.7% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $11M | $10M | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $10M | |
| Net Income TTM | $-8M | $-43M | $-47M | $-57M | $-45M | $-30M | $-32M | $-33M | $-53M | $-60M | $-59M | $-19M | |
| Market Cap | $13M | $26M | $75M | · | $8.72B | $14.99B | $1.13B | $458M | $11.49B | $43.47B | $37.54B | $12.90B | |
| Enterprise Value | $8M | $14M | · | · | $8.61B | $14.82B | $1.11B | $469M | $11.47B | $43.44B | $37.48B | $12.88B | |
| P/E | -1.7 | -0.4 | -1.4 | -0.9 | 190.4 | -268.5 | -35.1 | · | · | · | · | · | |
| P/S | 1.4 | 2.4 | 7.5 | · | 819.3 | 1383.3 | 113.0 | 43.9 | 1160.9 | 5774.7 | 4764.7 | 1311.0 | |
| P/B | 2.3 | -4.3 | 3.8 | · | 96.2 | 114.7 | -33.3 | -101.8 | 478.9 | 1485.2 | 581.9 | 433.3 | |
| P / Tangible Book | · | · | 7.0 | 28.3 | 106.8 | 123.2 | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | -0.7 | -2.0 | · | -231.9 | -582.3 | -43.1 | -15.2 | -237.6 | -1213.8 | -1255.8 | -767.5 | |
| P / FCF | · | · | -2.0 | · | -231.9 | -567.4 | -43.1 | -15.2 | -236.7 | -1202.7 | -1253.8 | -763.4 | |
| EV / EBITDA | -1.4 | -0.3 | · | · | -204.7 | -595.2 | -45.6 | -16.0 | -230.6 | -748.5 | -663.6 | -812.2 | |
| EV / FCF | · | · | · | · | -228.8 | -561.0 | -42.3 | -15.5 | -236.3 | -1202.0 | -1251.8 | -762.1 | |
| EV / Revenue | 0.8 | 1.2 | · | · | 808.4 | 1367.8 | 110.9 | 45.0 | 1159.1 | 5771.4 | 4757.3 | 1308.9 | |
| Earnings Yield | -58.6% | -224.8% | -70.3% | -110.4% | 0.53% | -0.37% | -2.9% | · | · | · | · | · |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| SG&A Expense | $3M | $5M | $3M | $4M | $4M | $4M | $3M | $4M | $5M | $5M | $5M | $5M | $4M | $5M | $4M | $5M | |
| Operating Expenses | $10M | $12M | $9M | $10M | $11M | $13M | $12M | $13M | $15M | $15M | $15M | $15M | $14M | $14M | $13M | $15M | |
| Operating Income | $-10M | $-12M | $20M | $-7M | $-8M | $-10M | $-9M | $-11M | $-13M | $-12M | $-12M | $-12M | $-12M | $-12M | $-10M | $-13M | |
| Interest Income | $62.0K | $77.0K | $51.0K | $80.0K | $92.0K | $93.0K | $227.0K | $325.0K | $701.0K | $515.0K | $665.0K | $806.0K | $815.0K | $652.0K | $542.0K | $335.0K | |
| Other Non-op | $1M | $-13M | $-263.0K | $-805.0K | $-342.0K | $-459.0K | $-624.0K | $475.0K | $709.0K | $593.0K | $487.0K | $187.0K | $177.0K | $68.0K | $-1M | $-688.0K | |
| Net Income | $-9M | $-24M | $19M | $-8M | $-9M | $-11M | $-10M | $-10M | $-12M | $-12M | $-12M | $-12M | $-12M | $-12M | $-11M | $-13M | |
| EPS (Basic) | $-4.02 | $-1.25 | $1.84 | $-0.49 | $-13.61 | $-1.25 | $-1.10 | $-1.70 | $-2.03 | $-2.05 | $-1.97 | $-2.13 | $-2.47 | $-2.39 | $-8.96 | $-2.83 | |
| EPS (Diluted) | $-4.02 | $-1.25 | $1.84 | $-0.49 | $-13.61 | $-1.25 | $-1.10 | $-1.70 | $-2.03 | $-2.05 | $-1.97 | $-2.13 | $-2.47 | $-2.39 | $-8.96 | $-2.83 | |
| Shares (Basic) | 2,135,906 | 19,363,478 | · | 15,680,178 | 631,475 | 8,493,886 | · | 5,940,924 | 5,818,416 | 5,783,585 | · | 5,720,789 | 4,834,381 | 4,830,763 | · | 4,689,559 | |
| Shares (Diluted) | 2,135,906 | 19,363,478 | · | 15,680,178 | 631,475 | 8,493,886 | · | 5,940,924 | 5,818,416 | 5,783,585 | · | 5,720,789 | 4,834,381 | 4,830,763 | · | 4,689,559 | |
| EBITDA | $-10M | $-12M | · | $-7M | $-8M | $-10M | · | $-11M | $-13M | $-12M | · | $-12M | $-12M | $-12M | · | $-13M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $15M | $5M | $9M | $10M | $20M | $20M | $21M | $10M | $30M | $27M | $24M | $20M | $32M | $20M | $30M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $18M | $11M | $30M | $44M | $44M | $40M | $66M | $69M | |
| Receivables | · | · | $0 | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $4M | $4M | $4M | |
| Current Assets | $7M | $17M | $7M | $14M | $14M | $25M | $26M | $27M | $35M | $46M | $61M | $73M | $68M | $78M | $92M | $106M | |
| PP&E (Net) | $46.0K | $54.0K | $62.0K | $98.0K | $130.0K | $172.0K | $231.0K | $246.0K | $308.0K | $370.0K | $434.0K | $497.0K | $561.0K | $625.0K | $689.0K | $780.0K | |
| PP&E (Gross) | · | · | $913.0K | · | · | · | $1M | · | · | · | $2M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $851.0K | · | · | · | $1M | · | · | · | $2M | · | · | · | $2M | · | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Total Assets | $19M | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M | $62M | $77M | $90M | $84M | $95M | $109M | $123M | |
| Accounts Payable | $5M | $7M | $6M | $4M | $4M | $5M | $3M | $4M | $2M | $4M | $3M | $5M | $3M | $3M | $3M | $6M | |
| Accrued Liabilities | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $8M | $7M | $6M | $9M | $7M | $6M | $4M | $6M | $7M | |
| Current Liabilities | $14M | $15M | $14M | $20M | $19M | $20M | $19M | $22M | $19M | $11M | $22M | $14M | $10M | $8M | $10M | $14M | |
| Capital Leases | $0 | $108.0K | $428.0K | $740.0K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | |
| Total Liabilities | $14M | $17M | $15M | $42M | $43M | $46M | $47M | $51M | $51M | $53M | $58M | $60M | $58M | $58M | $62M | $67M | |
| Total Debt | · | · | · | $7M | $7M | $7M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $400.0K | $129.0K | $127.0K | $107.0K | $105.0K | $85.0K | $60.0K | $59.0K | $59.0K | $59.0K | $59.0K | $993.0K | $966.0K | $48.0K | $964.0K | |
| Retained Earnings | $-1.28B | $-1.27B | $-1.25B | $-1.27B | $-1.26B | $-1.25B | $-1.24B | $-1.23B | $-1.22B | $-1.21B | $-1.20B | $-1.18B | $-1.17B | $-1.16B | $-1.15B | $-1.14B | |
| AOCI | · | · | · | · | · | · | · | $0 | $42.0K | $338.0K | $229.0K | $103.0K | $2.0K | $9.0K | $-186.0K | $-479.0K | |
| Stockholders' Equity | $5M | $13M | $5M | $-15M | $-14M | $-7M | $-6M | $-9M | $-694.0K | $9M | $20M | $30M | $26M | $37M | $47M | $56M | |
| Liabilities + Equity | $19M | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M | $62M | $77M | $90M | $84M | $95M | $109M | $123M | |
| Shares Outstanding | 1,949,041 | 39,978,693 | 12,928,853 | 12,733,853 | 10,708,393 | 10,462,250 | 8,487,818 | 6,020,259 | 5,904,278 | 5,894,085 | 5,894,085 | 5,885,313 | 99,344,798 | 96,617,898 | 4,830,464 | 96,398,360 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $36.0K | $32.0K | $42.0K | $59.0K | $16.0K | $61.0K | $62.0K | $64.0K | $64.0K | $63.0K | $64.0K | $64.0K | $92.0K | $61.0K | |
| Stock-based Comp | $569.0K | $575.0K | $795.0K | $924.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Operating Cash Flow | $-10M | $-9M | $-6M | $-6M | $-8M | $-7M | $-9M | $-6M | $-11M | $-13M | $-10M | $-8M | $-8M | $-12M | $-12M | $-13M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $52.0K | |
| Investing Cash Flow | $0 | $0 | $2M | $0 | $0 | $0 | $-428.0K | $18M | $-7M | $19M | $15M | $180.0K | $-3M | $26M | $3M | $4M | |
| Stock Issued | $-282.0K | $19M | $-119.0K | $6M | $-578.0K | $10M | $11M | $696.0K | $291.0K | $0 | $118.0K | $14M | $178.0K | $7.0K | $179.0K | · | |
| Net Stock Activity | · | $19M | · | · | · | $10M | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-282.0K | $19M | $-119.0K | $4M | $-2M | $8M | $9M | $-2M | $-1M | $-2M | $-2M | $13M | $-852.0K | $-2M | $-1M | $5M | |
| Net Change in Cash | $-10M | $10M | $-4M | $-1M | $-10M | $285.0K | $-857.0K | $11M | $-20M | $3M | $2M | $5M | $-12M | $12M | $-10M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-12M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -218.0% | -300.1% | -426.8% | · | -360.5% | -491.4% | -597.8% | · | -436.6% | -552.5% | -506.2% | · | -446.2% | |
| Net Margin | · | · | · | -243.4% | -312.6% | -446.0% | · | -344.3% | -463.6% | -569.3% | · | -430.0% | -544.4% | -503.2% | · | -470.6% | |
| EBITDA Margin | · | · | · | -218.0% | -300.1% | -426.8% | · | -360.5% | -491.4% | -597.8% | · | -436.6% | -552.5% | -506.2% | · | -446.2% | |
| ROA | -35.6% | -70.1% | · | -22.1% | -21.6% | -20.9% | · | -15.2% | -17.5% | -15.2% | · | -11.5% | -11.2% | -9.8% | · | -9.0% | |
| ROE | 184.7% | -793.4% | · | 66.0% | 117.1% | -743.7% | · | -96.8% | -92.5% | -51.6% | · | -28.5% | -27.1% | -20.5% | · | -16.8% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 1.1 | · | 0.7 | 0.7 | 1.2 | · | 1.2 | 1.8 | 4.1 | · | 5.4 | 7.0 | 9.7 | · | 7.7 | |
| Quick Ratio | 0.4 | 1.0 | · | 0.6 | 0.7 | 1.1 | · | 1.1 | 1.6 | 3.8 | · | 5.2 | 6.8 | 9.2 | · | 7.4 | |
| Debt / Equity | · | · | · | -0.5 | -0.5 | -1.1 | · | · | · | · | · | · | · | · | · | · |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 1.0 | 1.0 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 0.9 | 1.1 | · | 1.0 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.41 | $0.32 | · | $-1.15 | $-1.31 | $-0.63 | · | $-1.45 | $-0.12 | $1.61 | · | $5.03 | $0.26 | $0.38 | · | $0.58 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.20 | $0.22 | $0.28 | · | $0.49 | $0.44 | $0.36 | · | $0.50 | $0.02 | $0.02 | · | $0.03 | |
| Cash Flow / Share | · | $-0.46 | · | · | · | $-0.85 | · | · | · | $-2.29 | · | · | · | $-0.13 | · | · | |
| Cash / Share | $2.60 | $0.38 | · | $0.71 | $0.95 | $1.94 | · | $3.46 | $1.69 | $5.08 | · | $4.16 | $0.20 | $0.33 | · | $0.31 | |
| EPS (TTM) | $-3.92 | $-13.51 | · | $-16.45 | $-17.66 | $-6.08 | · | $-7.75 | $-8.18 | $-8.62 | · | $-15.95 | $-16.65 | $-14.35 | · | $-2.33 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $7M | · | $12M | $11M | $11M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | · | $10M | |
| Net Income TTM | $-21M | $-21M | · | $-37M | $-39M | $-42M | · | $-45M | $-48M | $-48M | · | $-47M | $-48M | $-52M | · | $-59M | |
| Market Cap | $1M | $22M | · | $21M | $25M | $22M | · | $32M | $41M | $64M | · | $39M | $1.65B | $1.16B | · | $1.35B | |
| Enterprise Value | · | · | · | $19M | $22M | $9M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.7 | -0.8 | · | -2.0 | -2.6 | -6.9 | · | -13.9 | -16.9 | -25.2 | · | -8.3 | -19.9 | -16.7 | · | -120.2 | |
| P/S | 4.7 | 62.3 | · | 36.3 | 43.6 | 39.2 | · | 63.3 | 80.2 | 130.6 | · | 75.9 | 3231.7 | 2229.2 | · | 2592.8 | |
| P/B | 0.2 | 1.7 | · | -1.4 | -1.8 | -3.3 | · | -3.7 | -58.7 | 6.8 | · | 1.3 | 62.9 | 31.7 | · | 24.2 | |
| P / Tangible Book | · | 5.9 | · | · | · | · | · | · | · | 133.5 | · | 1.9 | 95.6 | 42.0 | · | 28.9 | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.0 | · | · | · | -4.8 | · | · | · | -95.0 | · | · | |
| EV / Revenue | · | · | · | 36.1 | 43.3 | 38.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -37.7% | -122.8% | · | -49.5% | -38.1% | -14.5% | · | -7.2% | -5.9% | -4.0% | · | -12.1% | -5.0% | -6.0% | · | -0.83% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $9M | $11M | $10M | $10M | $11M |
| Marge d'exploitation % | -60.5% | -408.3% | -482.2% | · | -395.0% |
| Résultat net | $-8M | $-43M | $-47M | $-57M | $-45M |
| BPA dilué | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.0 | -1.3 | · | · | 0.0 |
| Ratio de liquidité | 0.5 | 1.4 | 4.5 | · | 9.1 |
| Ratio de liquidité réduite | 0.4 | 1.2 | 4.4 | · | 8.9 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | · | · | $-38M | · | $-38M |
Détenteurs institutionnels (13F) 39 déclarants · $8.3M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
39
Valeur détenue
$8.3M
Nouvelles positions
7
Positions clôturées
12
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 7 (-4 vs T. préc.) | 12 (+4 vs T. préc.) | 5 (-9 vs T. préc.) | 10 (+4 vs T. préc.) | -2.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Bleichroeder LP | $1 985 196 | 3 802 329 | 23,88% | Actions |
| Stonepine Capital Management, LLC | $1 729 292 | 3 312 185 | 20,80% | Actions |
| SPHERA FUNDS MANAGEMENT LTD. | $1 033 717 | 98 996 | 12,43% | Actions |
| Nantahala Capital Management, LLC | $1 033 171 | 1 978 876 | 12,43% | Actions |
| Cable Car Capital, LP | $696 134 | 1 333 334 | 8,37% | Actions |
| VANGUARD GROUP INC | $361 347 | 366 107 | 4,35% | Actions |
| CM Management, LLC | $287 155 | 550 000 | 3,45% | Actions |
| MORGAN STANLEY | $263 291 | 504 292 | 3,17% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $179 486 | 343 842 | 2,16% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $153 036 | 293 097 | 1,84% | Actions |
| M28 Capital Management LP | $148 741 | 284 889 | 1,79% | Actions |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $128 306 | 245 750 | 1,54% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $74 123 | 141 972 | 0,89% | Actions |
| XTX Topco Ltd | $56 470 | 108 160 | 0,68% | Actions |
| NORTHERN TRUST CORP | $50 054 | 95 870 | 0,60% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $32 189 | 61 664 | 0,39% | Actions |
| BlackRock, Inc. | $27 846 | 53 334 | 0,33% | Actions |
| Focused Wealth Management, Inc | $26 131 | 50 049 | 0,31% | Actions |
| STATE STREET CORP | $10 990 | 21 049 | 0,13% | Actions |
| FRANKLIN STREET ADVISORS INC /NC | $10 442 | 20 000 | 0,13% | Actions |
| LPL Financial LLC | $7 819 | 14 977 | 0,09% | Actions |
| MAVERICK CAPITAL LTD | $6 194 | 49 554 | 0,07% | Actions |
| Dauntless Investment Group, LLC | $5 222 | 10 001 | 0,06% | Actions |
| BARCLAYS PLC | $3 641 | 6 973 | 0,04% | Actions |
| Steward Partners Investment Advisory, LLC | $1 356 | 2 597 | 0,02% | Actions |
| OSAIC HOLDINGS, INC. | $785 | 1 510 | 0,01% | Actions |
| Axiom Investment Management LLC | $574 | 1 100 | 0,01% | Actions |
| GROUP ONE TRADING LLC | $235 | 450 | 0,00% | Actions |
| JPMORGAN CHASE & CO | $48 | 108 | 0,00% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $39 | 120 | 0,00% | Actions |
| WELLS FARGO & COMPANY/MN | $29 | 55 | 0,00% | Actions |
| CWM, LLC | $28 | 51 | 0,00% | Actions |
| UBS Group AG | $24 | 46 | 0,00% | Actions |
| GSA CAPITAL PARTNERS LLP | $12 | 22 760 | 0,00% | Actions |
| CIBC Private Wealth Group LLC | $10 | 6 | 0,00% | Actions |
| Blue Trust, Inc. | $2 | 4 | 0,00% | Actions |
| VIMA LLC | $2 | 3 | 0,00% | Actions |
| MPWM ADVISORY SOLUTIONS, LLC | $1 | 2 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $0 | 63 | 0,00% | Actions |
Activistes et détenteurs de 5%+ 3 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Personne déclarante non divulguée | 4 mars 2004 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée | 29 janvier 2004 | · | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée | 4 juin 2003 | · | Dépôt initial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 33 initiés · 17 dirigeants · 16 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| James E Dentzer | President & CEO | 7 juillet 2026 A | 148 730 | 0 | 0 | $0 |
| Ali Fattaey Ph.D. | President & CEO | 15 mai 2018 A | 322 140 | 0 | 0 | $0 |
| Diantha Duvall | CFO | 7 juillet 2026 A | 77 707 | 0 | 0 | $0 |
| William Steinkrauss | Chief Financial Officer | 29 janvier 2022 A | · | 0 | 0 | $0 |
| Michael Gray | CFO | 27 mai 2015 A | 107 304 | 0 | 0 | $0 |
| Mitchell Keegan | Vice-President | 7 janvier 2011 A | · | 0 | 0 | $0 |
| Jonathan B. Zung | CDO | 7 juillet 2026 A | 66 667 | 0 | 0 | $0 |
| Ahmed Hamdy MD | CMO | 20 mars 2026 C | 66 667 | 0 | 0 | $0 |
| Robert Martell | Head of Research & Development | 20 janvier 2023 A | 23 027 | 0 | 0 | $0 |
| David Tuck | Chief Medical Officer | 15 mai 2018 A | 169 424 | 0 | 0 | $0 |
| Mani Mohindru | Chief Strategy Officer | 14 février 2017 A | · | 0 | 0 | $0 |
| Jaye Viner | Chief Medical Officer | 27 mai 2015 A | · | 0 | 0 | $0 |
| Mark Noel | VP, Tech Management | 2 mai 2013 M | 27 540 | 0 | 0 | $0 |
| Changgeng Qian | VP, Research & Preclinical Dev | 7 janvier 2011 A | · | 0 | 0 | $0 |
| Mary Elizabeth Potthoff | VP and General Counsel | 31 mai 2006 A | 0 | 0 | 0 | $0 |
| Lee L Rubin | VP of Research | 1 juin 2005 A | 9 814 | 0 | 0 | $0 |
| Christopher U Missling | Sr. VP, Strategic Planning | 16 janvier 2004 M | 0 | 0 | 0 | $0 |
| Anne Elizabeth Borgman | Administrateur | 7 juillet 2026 A | · | 0 | 0 | $0 |
| John Hohneker | Administrateur | 7 juillet 2026 A | · | 0 | 0 | $0 |
| Marc Rubin | Administrateur | 7 juillet 2026 A | 28 108 | 0 | 0 | $0 |
| Kenneth I Kaitin | Administrateur | 7 juillet 2026 A | 11 407 | 1 | 0 | $5 500 |
| Martyn D Greenacre | Administrateur | 7 juillet 2026 A | 26 089 | 0 | 0 | $0 |
| Lori Anne Kunkel | Administrateur | 31 janvier 2022 A | 22 200 | 0 | 0 | $0 |
| James R Mcnab | Administrateur | 5 mai 2017 S | 50 000 | 0 | 0 | $0 |
| Kenneth Pienta | Administrateur | 28 février 2017 A | 30 000 | 0 | 0 | $0 |
| James R Tobin | Administrateur | 26 janvier 2015 A | 144 921 | 0 | 0 | $0 |
| Susan B Bayh | Administrateur | 17 janvier 2013 A | 25 000 | 0 | 0 | $0 |
| Joseph Davie MD PHD | Administrateur | 7 janvier 2011 A | · | 0 | 0 | $0 |
| Stephen Carter | Administrateur | 25 janvier 2008 A | · | 0 | 0 | $0 |
| Joseph M Davie | Administrateur | 6 juin 2007 A | 20 000 | 0 | 0 | $0 |
| Douglas Melton | Administrateur | 23 août 2006 A | 173 499 | 0 | 0 | $0 |
| Daniel R Passeri | · | 19 janvier 2016 A | 211 798 | 0 | 0 | $0 |
| Maurizio Voi | · | 17 janvier 2013 A | · | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 2 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
CRIS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 10 analystes
ACHAT
Objectif médian
$43.00
+5252,3%
2 20,0%
Achat fort
7 70,0%
Achat
1 10,0%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
3 analystes · 2026-10-01Objectif moyen $42.67 +5210,8%
← En dessous de tous les objectifs
Prix actuel $0.80
Bas$20.00
Moyenne$42.67
Haut$65.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 14, 2026